China's NMPA grants CanSino Biologics approval for clinical trials of recombinant trivalent poliomyelitis vaccine
China's NMPA grants CanSino Biologics approval for clinical trials of recombinant trivalent poliomyelitis vaccine
News
-
CPIVC NEWS
Sinovac's tetanus vaccine gets medical body's approval
Sinovac's tetanus vaccine gets medical body's approval
learn more »
CPIVC 2025-09-24
-
CPIVC NEWS
Regulatory Approval for CNBG’s Rotavirus Vaccine, Rotasiro® by NMPA
Regulatory Approval for CNBG’s Rotavirus Vaccine, Rotasiro® by NMPA
learn more »
CPIVC 2025-09-24
-
CPIVC NEWS
China's first domestically developed nine-valent HPV vaccine priced at $70 per dose
China's first domestically developed nine-valent HPV vaccine priced at $70 per dose
learn more »
CPIVC 2025-09-24
-
CPIVC NEWS
Hepatitis vaccine gets thumbs up from China's health regulators
Hepatitis vaccine gets thumbs up from China's health regulators
learn more »
CPIVC 2025-09-24
-
CPIVC NEWS
Biological E to make HPV9 vaccine under licensing pact with Recbio
Biological E to make HPV9 vaccine under licensing pact with Recbio
learn more »
CPIVC 2025-09-24
-
CPIVC NEWS
NMPA holds meeting to review QMS in vaccine regulation, pharmaceutical manufacturing inspection
NMPA holds meeting to review QMS in vaccine regulation, pharmaceutical manufacturing inspection
learn more »
CPIVC 2025-09-23
Scan the QR code to follow
us on WeChat
京公网安备 11010802041931号 © 2024 cpivc.com